CliffBio
small molecule

EXCEDRIN (MIGRAINE RELIEF)

ACETAMINOPHEN; ASPIRIN; CAFFEINE

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameEXCEDRIN (MIGRAINE RELIEF)
Active ingredientACETAMINOPHEN; ASPIRIN; CAFFEINE
Strength250MG;250MG;65MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 1998
Marketing statusOTC

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.